Functional Assessment of the Quality of Human Hepatocyte Preparations for Cell Transplantation
Autors de IIS La Fe
Grups d'Investigació
Abstract
Hepatocyte transplantation is an alternative therapy to orthotopic liver transplantation for the treatment of liver diseases. Good quality freshly isolated or cryopreserved human hepatocytes are needed for clinical transplantation. However, isolation, cryopreservation, and thawing processes can seriously impair hepatocyte viability and functionality. The aim of the present study was to develop a fast and sensitive procedure to estimate the quality of hepatocyte preparations prior to clinical cell infusion. To this end, cell viability, attachment efficiency, and metabolic competence (urea synthesis and drug-metabolizing P450 activities) were selected as objective criteria. Viability of hepatocyte suspension was estimated by trypan blue staining. DNA content of attached cells 50 min after hepatocyte platting to fibronectin/collagen-coated dishes was quantified to estimate adherence capacity. Urea production was determined after incubating hepatocyte suspensions with 2 mM CINH4 for 30 min. The cytochrome P450 function was assayed by a 30-min incubation of hepatocyte suspension with a cocktail mixture containing selective substrates for seven individual P450 activities (CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4). The assay can be applied to both freshly isolated and cryopreserved hepatocyte suspensions, and the results are available within 1 h, which could help to make short-term decisions: 1) to assess the suitability for cell transplantation of a preparation of freshly isolated hepatocytes or a particular batch of thawed cells, or 2) to estimate the convenience of banking a particular cell preparation.
Dades de la publicació
- ISSN/ISSNe:
- 0963-6897, 1555-3892
- Tipus:
- Article
- Pàgines:
- 1211-1219
- PubMed:
- 19181215
- Factor d'Impacte:
- 0,880 SCImago ℠
- Quartil:
- Q2 SCImago ℠
CELL TRANSPLANTATION COGNIZANT COMMUNICATION CORP
Cites Rebudes en Web of Science: 47
Documents
- No hi ha documents
Filiacions
Filiacions no disponibles
Projectes associats
DESARROLLO DE UN MODELO HEPATOCELULAR HUMANO DIFERENCIADO PARA ESTUDIOS DE METABOLISMO Y POTENCIAL INDUCTOR DE NUEVOS FARMACOS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
SAF2003-09353 . 2003
A-CUTE-TOX
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
LSHB-CT-2004-512051-ACUTE TOX . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2005
DESARROLLO DE NUEVAS ESTRATEGIAS DIAGNOSTICAS BASADAS EN EL ESTUDIO DE LA CAPACIDAD METABOLIZANTE DE LA PIEL Y DEL PAPEL DE LAS CELULAS DENDITRICAS EN LA INDUCCION DE LAS REACCIONES ALERGICAS FRENTE A FARMACOS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
PARTIC PI05/2290 - FUND IMABIS . INSTITUTO DE SALUD CARLOS III; FUNDACION FIMABIS . 2007
DEVELOPMENT OF A HIGH THROUGHPUT GENOMICS-BASED TEST FOR ASSESSING GENOTOXIC AND CARCINOGENIC PROPERTIES OF CHEMICAL COMPOUNDS IN VITRO
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
CARCINOGENOMICS . COMISION EUROPEA . 2006
LINTOP
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
LSHB-CT-2006-037499 - LINTOP . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2005
MECANISMOS TRNACRIPCIONALES IMPLICADOS EN LA ETIOLOGIA DEL HIGADO GRASO NO ALCOHOLICO. ESTUDIOS EN UN MODELO CELULAR HUMANO DE ESTEATOSIS Y APLICACION AL TRANSPLANTE DE HEPATOCITOS EN TERAPIA CELULAR.
Investigador Principal: RAMIRO JOVER ATIENZA
PI07/0550 . INSTITUTO DE SALUD CARLOS III . 2007
TU HOSPITAL INVESTIGA PARA TI
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
CCT005-07-00936 . 2007
FORINVITOX
Investigador Principal: MARÍA JOSÉ GÓMEZ-LECHÓN MOLINER
FORINVITOX 1, START UP 2 . REMA; UNIVERSIDAD AUTONOMA BARCELONA; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2008